GEFITINIB — all Canadian products
7 DINs
5 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is GEFITINIB, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02468050 | APO-GEFITINIB | APOTEX INC | Tablet | Oral | GEFITINIB 250 MG | Marketed | |
| 02533685 | AURO-GEFITINIB | AURO PHARMA INC | Tablet | Oral | GEFITINIB 250 MG | Approved | |
| 02547546 | EUGIA-GEFITINIB | EUGIA PHARMA INC. | Tablet | Oral | GEFITINIB 250 MG | Approved | |
| 02248676 | IRESSA | ASTRAZENECA CANADA INC | Tablet | Oral | GEFITINIB 250 MG | Marketed | |
| 02500663 | JAMP GEFITINIB | JAMP PHARMA CORPORATION | Tablet | Oral | GEFITINIB 250 MG | Marketed | |
| 02491796 | NAT-GEFITINIB | NATCO PHARMA (CANADA) INC | Tablet | Oral | GEFITINIB 250 MG | Dormant | |
| 02487748 | SANDOZ GEFITINIB | SANDOZ CANADA INCORPORATED | Tablet | Oral | GEFITINIB 250 MG | Cancelled Post Market |
Browse other molecules: